Artefactual subcortical hyperperfusion in PET studies normalized to global mean: Lessons from Parkinson's disease

被引:71
作者
Borghammer, Per [1 ]
Cumming, Paul [2 ]
Aanerud, Joel [1 ]
Gjedde, Albert [1 ,3 ]
机构
[1] Aarhus Univ Hosp, PET Ctr, DK-8000 Aarhus C, Denmark
[2] Univ Munich, Munich, Germany
[3] Aarhus Univ, CFIN, DK-8000 Aarhus, Denmark
基金
美国国家科学基金会;
关键词
Parkinson's disease; Energy metabolism; CBF; White matter; Normalization; CEREBRAL-BLOOD-FLOW; MULTIPLE SYSTEM ATROPHY; GLUCOSE-METABOLISM; COGNITIVE IMPAIRMENT; ALZHEIMERS-DISEASE; OXYGEN-METABOLISM; FDG-PET; 1-METHYL-4-PHENYL-1,2,3,6-TETRAHYDROPYRIDINE MPTP; STATISTICAL APPROACH; EMISSION TOMOGRAPHY;
D O I
10.1016/j.neuroimage.2008.07.042
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Aim: Recent studies of Parkinson's disease (PD) report subcortical increases of cerebral blood flow (CBF) or cerebral metabolic rate of glucose (CMRglc), after conventional normalization to the global mean. However, if the global mean CBF or CMRglc is decreased in the PD group, this normalization necessarily generates artificial relative increases in regions unaffected by the disease. This potential bias may explain the reported subcortical increases in PD. To test this hypothesis, we performed simulations with manipulation and subsequently analysis of sets of quantitative CBF maps by voxel-based statistics. Materials and methods: CBF images from 49 healthy volunteers were randomly assigned to four sets of two groups of 20 subjects. For each set, CBF images in one group were manipulated, while the other group served as controls. In the first simulation, an isolated cortical decrease was simulated. In the second simulation, focal increases in the globus pallidus and thalamus motor nuclei were simulated in addition to cortical decreases, thus emulating the putative metabolic pattern in PD. The data were analyzed with both the SSM method and a univariate statistical approach with normalization to either the global mean or to the white matter mean. Results: In Simulation I, global normalization robustly created artefactual subcortical increases, irrespective of analysis methodology. Simulation II demonstrated that an increased signal from the small subcortical structures involved in PD can probably not be detected with present instrumentation and typically-used sample sizes. Conclusion: Imposing focal decreases on cortical CBF in conjunction with global mean normalization gives rise to spurious relative CBF increases in all of the regions reported to be hyperactive in PD. Since no PET study has reported absolute increases of CBF or CMRglc in any subcortical region in PD, we conclude that the relative increases reported in some studies most likely arise from biased normalization to the global mean. (c) 2008 Elsevier Inc. All rights reserved.
引用
收藏
页码:249 / 257
页数:9
相关论文
共 79 条
  • [11] DEFEBVRE L, 1995, ACTA NEUROL SCAND, V92, P235
  • [12] Regional cerebral blood flow in Parkinson's disease as an indicator of cognitive impairment
    Derejko, Miroslawa
    Slawek, Jaroslaw
    Wieczorek, Dariusz
    Brockhuis, Bogna
    Dubaniewicz, Miroslawa
    Lass, Piotr
    [J]. NUCLEAR MEDICINE COMMUNICATIONS, 2006, 27 (12) : 945 - 951
  • [13] CORTICAL GLUCOSE-METABOLISM IN PARKINSONS-DISEASE WITHOUT DEMENTIA
    EBERLING, JL
    RICHARDSON, BC
    REED, BR
    WOLFE, N
    JAGUST, WJ
    [J]. NEUROBIOLOGY OF AGING, 1994, 15 (03) : 329 - 335
  • [14] FDG PET in the differential diagnosis of parkinsonian disorders
    Eckert, T
    Barnes, A
    Dhawan, V
    Frucht, S
    Gordon, MF
    Feigin, AS
    Eidelberg, D
    [J]. NEUROIMAGE, 2005, 26 (03) : 912 - 921
  • [15] Quantification of Parkinson's disease-related network expression with ECD SPECT
    Eckert, Thomas
    Van Laere, Koen
    Tang, Chengke
    Lewis, Daniel E.
    Edwards, Christine
    Santens, Patrick
    Eidelberg, David
    [J]. EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2007, 34 (04) : 496 - 501
  • [16] THE METABOLIC ANATOMY OF PARKINSONS-DISEASE - COMPLEMENTARY [F-18] FLUORODEOXYGLUCOSE AND [F-18] FLUORODOPA POSITRON EMISSION TOMOGRAPHIC STUDIES
    EIDELBERG, D
    MOELLER, JR
    DHAWAN, V
    SIDTIS, JJ
    GINOS, JZ
    STROTHER, SC
    CEDARBAUM, J
    GREENE, P
    FAHN, S
    ROTTENBERG, DA
    [J]. MOVEMENT DISORDERS, 1990, 5 (03) : 203 - 213
  • [17] THE METABOLIC TOPOGRAPHY OF PARKINSONISM
    EIDELBERG, D
    MOELLER, JR
    DHAWAN, V
    SPETSIERIS, P
    TAKIKAWA, S
    ISHIKAWA, T
    CHALY, T
    ROBESON, T
    MARGOULEFF, D
    PRZEDBORSKI, S
    FAHN, S
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1994, 14 (05) : 783 - 801
  • [18] Metabolic correlates of levodopa response in Parkinson's disease
    Feigin, A
    Fukuda, M
    Dhawan, V
    Przedborski, S
    Jackson-Lewis, V
    Mentis, MJ
    Moeller, JR
    Eidelberg, D
    [J]. NEUROLOGY, 2001, 57 (11) : 2083 - 2088
  • [19] Regional cerebral blood flow in Parkinson's disease with and without dementia
    Firbank, M
    Colloby, ST
    Burn, D
    McKeith, IG
    O'Brien, JT
    [J]. NEUROIMAGE, 2003, 20 (02) : 1309 - 1319
  • [20] THE RELATIONSHIP BETWEEN GLOBAL AND LOCAL CHANGES IN PET SCANS
    FRISTON, KJ
    FRITH, CD
    LIDDLE, PF
    DOLAN, RJ
    LAMMERTSMA, AA
    FRACKOWIAK, RSJ
    [J]. JOURNAL OF CEREBRAL BLOOD FLOW AND METABOLISM, 1990, 10 (04) : 458 - 466